{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:41:39Z","timestamp":1791268899736,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/bor.0b013e328358bd85","type":"journal-article","created":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T10:37:11Z","timestamp":1346927831000},"page":"602-608","source":"Crossref","is-referenced-by-count":122,"title":["Myositis autoantibodies"],"prefix":"10.1097","volume":"24","author":[{"given":"Livia","family":"Casciola-Rosen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Mammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210128","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2009.05119.x","article-title":"Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis.","volume":"1184","author":"Mammen","year":"2010","journal-title":"Ann NY Acad Sci"},{"key":"R2-4-20210128","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/nar\/29.12.2517","article-title":"Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor.","volume":"29","author":"Wang","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"R3-4-20210128","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0092-8674(00)81758-4","article-title":"The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.","volume":"95","author":"Zhang","year":"1998","journal-title":"Cell"},{"key":"R4-4-20210128","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1242\/dev.001750","article-title":"The chromatin remodeler Mi-2beta is required for establishment of the basal epidermis and normal differentiation of its progeny.","volume":"134","author":"Kashiwagi","year":"2007","journal-title":"Development"},{"key":"R5-4-20210128","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy.","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J Exp Med"},{"key":"R6-4-20210128","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.24977","article-title":"Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle.","volume":"60","author":"Mammen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R7-4-20210128","doi-asserted-by":"crossref","first-page":"34976","DOI":"10.1074\/jbc.M805383200","article-title":"UV radiation regulates Mi-2 through protein translation and stability.","volume":"283","author":"Burd","year":"2008","journal-title":"J Biol Chem"},{"key":"R8-4-20210128","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis.","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R9-4-20210128","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","article-title":"RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease.","volume":"60","author":"Sato","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R10-4-20210128","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","article-title":"The RIG-I-like receptor IFIH1MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody.","volume":"49","author":"Nakashima","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study.","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R12-4-20210128","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MD.0b013e3182606f0b","article-title":"A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature.","volume":"91","author":"Chaisson","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"R13-4-20210128","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pharmthera.2009.06.012","article-title":"Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity.","volume":"124","author":"Barral","year":"2009","journal-title":"Pharmacol Ther"},{"key":"R14-4-20210128","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alphabeta-mediated innate immune mechanisms in dermatomyositis.","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"R15-4-20210128","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/ar3347","article-title":"The lung as a possible target for the immune reaction in myositis.","volume":"13","author":"Danoff","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R16-4-20210128","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis.","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R17-4-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","article-title":"Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy.","volume":"46","author":"Kaji","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R18-4-20210128","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.33379","article-title":"Usefulness of antip155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis.","volume":"64","author":"Trallero-Araguas","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R19-4-20210128","first-page":"S518","article-title":"Autoantibodies to transcriptional intermediary factor 1-gamma (TIF1-g) in dermatomyositis abstract.","volume":"55","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R20-4-20210128","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.33403","article-title":"Myositis-specific anti155140 autoantibodies target transcription intermediary factor 1 family proteins.","volume":"64","author":"Fujimoto","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cell.2008.10.051","article-title":"FAMUSP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination.","volume":"136","author":"Dupont","year":"2009","journal-title":"Cell"},{"key":"R22-4-20210128","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1073\/pnas.0813177106","article-title":"Trim24 targets endogenous p53 for degradation.","volume":"106","author":"Allton","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R23-4-20210128","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nature09542","article-title":"TRIM24 links a noncanonical histone signature to breast cancer.","volume":"468","author":"Tsai","year":"2010","journal-title":"Nature"},{"key":"R24-4-20210128","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.emboj.7600791","article-title":"MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.","volume":"24","author":"Wang","year":"2005","journal-title":"EMBO J"},{"key":"R25-4-20210128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4049\/jimmunol.179.1.26","article-title":"Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages.","volume":"179","author":"Kong","year":"2007","journal-title":"J Immunol"},{"key":"R26-4-20210128","first-page":"S139","article-title":"Clinical and serological characterisation of the anti-MJ antibody in childhood myositis.","volume":"40","author":"Oddis","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R27-4-20210128","first-page":"S787","article-title":"Sera with autoantibodies to the MJ antigen react with NXP2.","volume":"56","author":"Targoff","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R28-4-20210128","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","article-title":"Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.","volume":"60","author":"Gunawardena","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R29-4-20210128","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.3899\/jrheum.090461","article-title":"Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein.","volume":"36","author":"Espada","year":"2009","journal-title":"J Rheumatol"},{"key":"R30-4-20210128","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","article-title":"Anti-MJNXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositisdermatomyositis.","volume":"14","author":"Ceribelli","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R31-4-20210128","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","article-title":"Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.","volume":"71","author":"Ichimura","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R32-4-20210128","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","article-title":"Human autoantibodies reactive with the signal-recognition particle.","volume":"83","author":"Reeves","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"R33-4-20210128","first-page":"1727","article-title":"Novel autoantibodies against 7SL RNA in patients with polymyositisdermatomyositis.","volume":"32","author":"Satoh","year":"2005","journal-title":"J Rheumatol"},{"key":"R34-4-20210128","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.1780330908","article-title":"Antibody to signal recognition particle in polymyositis.","volume":"33","author":"Targoff","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R35-4-20210128","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: clinical and pathological features.","volume":"73","author":"Miller","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R36-4-20210128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","article-title":"Antisignal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.","volume":"50","author":"Kao","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R37-4-20210128","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","article-title":"Antisignal recognition particle autoantibodies: marker of a necrotising myopathy.","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R38-4-20210128","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/acr.20219","article-title":"Rituximab therapy for myopathy associated with antisignal recognition particle antibodies: a case series.","volume":"62","author":"Valiyil","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R39-4-20210128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"R40-4-20210128","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archneurol.2011.1728","article-title":"Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome.","volume":"69","author":"Suzuki","year":"2012","journal-title":"Arch Neurol"},{"key":"R41-4-20210128","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar1895","article-title":"Human autoantibodies against the 54 kDa protein of the signal recognition particle block function at multiple stages.","volume":"8","author":"Romisch","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"R42-4-20210128","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.30344","article-title":"Correlation of antisignal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.","volume":"63","author":"Benveniste","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R43-4-20210128","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy.","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R44-4-20210128","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2006.10.007","article-title":"Progressive myopathy with up-regulation of MHC-I associated with statin therapy.","volume":"17","author":"Needham","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"R45-4-20210128","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotizing myopathy associated with statins.","volume":"41","author":"Grable-Esposito","year":"2010","journal-title":"Muscle Nerve"},{"key":"R46-4-20210128","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R47-4-20210128","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/acr.20662","article-title":"Rarity of anti3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects.","volume":"64","author":"Mammen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R48-4-20210128","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/acr.21671","article-title":"Increased frequency of DRB111:01 in anti-HMG-CoA reductase-associated autoimmune myopathy.","volume":"64","author":"Mammen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e328358bd85","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T23:53:42Z","timestamp":1714348422000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201211000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e328358bd85","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}